Suppr超能文献

肾脏上皮转运体的血管控制。

Vascular control of kidney epithelial transporters.

机构信息

Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Renal Section, Durham Veterans Affairs Health Care System, Durham, North Carolina.

出版信息

Am J Physiol Renal Physiol. 2021 Jun 1;320(6):F1080-F1092. doi: 10.1152/ajprenal.00084.2021. Epub 2021 May 10.

Abstract

A major pathway in hypertension pathogenesis involves direct activation of ANG II type 1 (AT) receptors in the kidney, stimulating Na reabsorption. AT receptors in tubular epithelia control expression and stimulation of Na transporters and channels. Recently, we found reduced blood pressure and enhanced natriuresis in mice with cell-specific deletion of AT receptors in smooth muscle (SMKO mice). Although impaired vasoconstriction and preserved renal blood flow might contribute to exaggerated urinary Na excretion in SMKO mice, we considered whether alterations in Na transporter expression might also play a role; therefore, we carried out proteomic analysis of key Na transporters and associated proteins. Here, we show that levels of Na-K-2Cl cotransporter isoform 2 (NKCC2) and Na/H exchanger isoform 3 (NHE3) are reduced at baseline in SMKO mice, accompanied by attenuated natriuretic and diuretic responses to furosemide. During ANG II hypertension, we found widespread remodeling of transporter expression in wild-type mice with significant increases in the levels of total NaCl cotransporter, phosphorylated NaCl cotransporter (Ser), and phosphorylated NKCC2, along with the cleaved, activated forms of the α- and γ-epithelial Na channel. However, the increases in α- and γ-epithelial Na channel with ANG II were substantially attenuated in SMKO mice. This was accompanied by a reduced natriuretic response to amiloride. Thus, enhanced urinary Na excretion observed after cell-specific deletion of AT receptors from smooth muscle cells is associated with altered Na transporter abundance across epithelia in multiple nephron segments. These findings suggest a system of vascular-epithelial in the kidney, modulating the expression of Na transporters and contributing to the regulation of pressure natriuresis. The use of drugs to block the renin-angiotensin system to reduce blood pressure is common. However, the precise mechanism for how these medications control blood pressure is incompletely understood. Here, we show that mice lacking angiotensin receptors specifically in smooth muscle cells lead to alternation in tubular transporter amount and function. Thus, demonstrating the importance of vascular-tubular cross talk in the control of blood pressure.

摘要

高血压发病机制中的一个主要途径涉及在肾脏中直接激活血管紧张素 II 型 1(AT)受体,刺激钠重吸收。肾小管上皮细胞中的 AT 受体控制钠转运体和通道的表达和刺激。最近,我们发现平滑肌中特异性缺失 AT 受体的小鼠(SMKO 小鼠)血压降低和尿钠排泄增加。尽管血管收缩受损和肾血流量保留可能导致 SMKO 小鼠尿钠排泄增加,但我们考虑钠转运体表达的改变是否也起作用;因此,我们对关键钠转运体和相关蛋白进行了蛋白质组学分析。在这里,我们表明,SMKO 小鼠基础状态下的钠-钾-2 氯共转运体 2 型(NKCC2)和钠/氢交换体 3 型(NHE3)的水平降低,同时对呋塞米的利尿和排钠反应减弱。在血管紧张素 II 性高血压期间,我们发现野生型小鼠的转运体表达广泛重塑,总氯化钠共转运体、磷酸化氯化钠共转运体(Ser)和磷酸化 NKCC2 的水平显著增加,同时α-和γ-上皮钠通道的裂解、激活形式也增加。然而,SMKO 小鼠中 ANG II 引起的α-和γ-上皮钠通道的增加明显减弱。这伴随着对阿米洛利的排钠反应减弱。因此,平滑肌细胞特异性缺失 AT 受体后观察到的尿钠排泄增加与多个肾单位节段上皮细胞中钠转运体丰度的改变有关。这些发现表明,肾脏中的血管-上皮系统调节钠转运体的表达,有助于压力排钠的调节。使用药物阻断肾素-血管紧张素系统以降低血压是常见的。然而,这些药物如何控制血压的精确机制尚不完全清楚。在这里,我们表明,特异性缺失平滑肌细胞中血管紧张素受体的小鼠导致管状转运体数量和功能改变。因此,证明了血管-管状交叉对话在控制血压中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47df/8285646/b8093f5016a1/f-00084-2021r01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验